Great Lakes Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Great Lakes Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$107.32 - $113.5 $60,850 - $64,354	-567 Reduced 23.24%	1,873 $204,000
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $152,231 - $277,672	2,440 New	2,440 $277,000
Q2 2022 Aug 09, 2022	SELL	$79.4 - $116.36 $18,500 - $27,111	-233 Reduced 7.4%	2,915 $233,000
Q1 2022 May 06, 2022	SELL	$86.42 - $109.81 $64,296 - $81,698	-744 Reduced 19.12%	3,148 $331,000
Q4 2021 Feb 09, 2022	SELL	$98.56 - $119.91 $17,248 - $20,984	-175 Reduced 4.3%	3,892 $419,000
Q3 2021 Nov 09, 2021	SELL	$91.91 - $110.37 $58,822 - $70,636	-640 Reduced 13.6%	4,067 $445,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $4,053 - $4,508	-47 Reduced 0.99%	4,707 $441,000
Q1 2021 May 03, 2021	BUY	$71.83 - $95.48 $16,880 - $22,437	235 Added 5.2%	4,754 $438,000
Q4 2020 Feb 09, 2021	SELL	$67.0 - $84.39 $6,767 - $8,523	-101 Reduced 2.19%	4,519 $331,000
Q3 2020 Nov 04, 2020	BUY	$55.23 - $79.93 $36,838 - $53,313	667 Added 16.87%	4,620 $359,000
Q2 2020 Aug 07, 2020	BUY	$30.2 - $56.98 $119,380 - $225,241	3,953 New	3,953 $220,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.